naphthalimides has been researched along with Age-Related Osteoporosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cary, RL; Long, F; Novack, DV; Racioppi, L; Sankar, U; Voor, MJ; Waddell, S | 1 |
Cary, RL; Novack, DV; Pritchard, ZJ; Sankar, U; Voor, MJ; Yang, C | 1 |
2 other study(ies) available for naphthalimides and Age-Related Osteoporosis
Article | Year |
---|---|
Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
Topics: Adult; Animals; Benzimidazoles; Bone Marrow Cells; Bone Remodeling; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cell Differentiation; CREB-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Female; Humans; Mesenchymal Stem Cells; Mice; Mice, Knockout; Naphthalimides; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteoporosis; Ovariectomy | 2013 |
Inhibition of CaMKK2 reverses age-associated decline in bone mass.
Topics: Animals; Benzimidazoles; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Compressive Strength; Disease Models, Animal; Enzyme Inhibitors; Femur; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalimides; Osteogenesis; Osteoporosis; X-Ray Microtomography | 2015 |